Target Name: ZMYM4
NCBI ID: G9202
Review Report on ZMYM4 Target / Biomarker Content of Review Report on ZMYM4 Target / Biomarker
ZMYM4
Other Name(s): zinc finger protein 262 | DKFZp686B09210 | zinc finger MYM-type containing 4 | ZNF262 | ZMYM4 variant 1 | Cell death inhibiting RNA | CDIR | Zinc finger MYM-type protein 4 | DKFZp686L0547 | Zinc finger MYM-type containing 4, transcript variant 1 | Zinc finger MYM-type protein 4 (isoform 1) | KIAA0425 | zinc finger, MYM-type 4 | cell death inhibiting RNA | MYM | Zinc finger protein 262 | ZMYM4_HUMAN | ZNF198L3

ZMYM4: The Potential Drug Target and Biomarker for Zinc Finger Proteins

Zinc finger proteins (ZFPs) are a family of non-coding RNAs that play a crucial role in various cellular processes. ZMYM4, a ZFP located in the human chromosome 17, has been identified as a potential drug target and biomarker for various diseases. In this article, we will discuss the biology of ZMYM4, its potential drug targeting capabilities, and its potential as a biomarker for disease diagnosis and treatment.

Biography of ZMYM4

ZMYM4 is a 262-amino acid long ZFP that is located on the long arm of chromosome 17 at position 161.3. It is a cDNA-containing gene that encodes a protein with 262 amino acid residues. ZMYM4 is a nuclear protein that is predominantly localized to the nucleoplasm.

Function of ZMYM4

ZMYM4 is a key regulator of gene expression and has been shown to play a role in various cellular processes. It is a negative regulator of the Myc gene, which encodes the muscle protein myosin. ZMYM4 functions by binding to the Myc gene and preventing its translation into protein. This interaction between ZMYM4 and Myc has been shown to play a role in the regulation of muscle growth, differentiation, and function.

Potential Drug Target

ZMYM4 has been identified as a potential drug target due to its unique structure and its involvement in various cellular processes. The zinc finger domain of ZMYM4 is known for its ability to interact with various small molecules, including drugs. This interaction has led to the suggestion that ZMYM4 may be a drug target for various diseases.

One of the potential drug targets for ZMYM4 is cancer. ZMYM4 has been shown to be involved in the regulation of cell cycle progression and has been implicated in the development and progression of various cancers. ZMYM4 has also been shown to play a role in the regulation of apoptosis, which is a critical mechanism for cancer cell death.

In addition to its potential cancer-related functions, ZMYM4 has also been implicated in the regulation of neurodegenerative diseases. ZMYM4 has been shown to play a role in the regulation of neurotransmitter synthesis and release, which is important for the function of the nervous system.

Potential Biomarker

ZMYM4 has also been identified as a potential biomarker for various diseases. Its involvement in the regulation of cellular processes makes it a potential indicator of disease status. For example, ZMYM4 has been shown to be involved in the regulation of muscle growth and function, which is important for maintaining physical mobility.

In addition to its involvement in muscle function, ZMYM4 has also been shown to play a role in the regulation of inflammation. Its involvement in this process makes it a potential indicator of inflammation and its levels may be relevant as a biomarker for various inflammatory diseases.

Conclusion

In conclusion, ZMYM4 is a unique ZFP that has been identified as a potential drug target and biomarker for various diseases. Its functions in regulating gene expression and cellular processes make it a valuable tool for the development of new treatments for a variety of diseases. Further research is needed to fully understand the role of ZMYM4 in disease progression and to explore its potential as a biomarker for disease diagnosis and treatment.

Protein Name: Zinc Finger MYM-type Containing 4

Functions: Plays a role in the regulation of cell morphology and cytoskeletal organization

The "ZMYM4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZMYM4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZMYM4-AS1 | ZMYM5 | ZMYM6 | ZMYND10 | ZMYND11 | ZMYND12 | ZMYND15 | ZMYND19 | ZMYND8 | ZNF10 | ZNF100 | ZNF101 | ZNF106 | ZNF107 | ZNF112 | ZNF114 | ZNF117 | ZNF12 | ZNF121 | ZNF124 | ZNF131 | ZNF132 | ZNF133 | ZNF134 | ZNF135 | ZNF136 | ZNF137P | ZNF138 | ZNF14 | ZNF140 | ZNF141 | ZNF142 | ZNF143 | ZNF146 | ZNF148 | ZNF154 | ZNF155 | ZNF157 | ZNF16 | ZNF160 | ZNF165 | ZNF169 | ZNF17 | ZNF174 | ZNF175 | ZNF177 | ZNF18 | ZNF180 | ZNF181 | ZNF182 | ZNF184 | ZNF185 | ZNF189 | ZNF19 | ZNF195 | ZNF197 | ZNF2 | ZNF20 | ZNF200 | ZNF202 | ZNF204P | ZNF205 | ZNF205-AS1 | ZNF207 | ZNF208 | ZNF209P | ZNF211 | ZNF212 | ZNF213 | ZNF213-AS1 | ZNF214 | ZNF215 | ZNF217 | ZNF219 | ZNF22 | ZNF22-AS1 | ZNF221 | ZNF222 | ZNF223 | ZNF224 | ZNF225 | ZNF225-AS1 | ZNF226 | ZNF227 | ZNF229 | ZNF23 | ZNF230 | ZNF232 | ZNF232-AS1 | ZNF233 | ZNF234 | ZNF235 | ZNF236 | ZNF236-DT | ZNF239 | ZNF24 | ZNF248 | ZNF25 | ZNF250 | ZNF251